| Metric | შპს SmartPharm | სს თიბისი ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾36.6m₾31.6m | ₾2.36bn₾2.11bn |
| Revenue growth | 15.9% | 11.8% |
| Profitability | ||
| EBITDA | ₾2.0m₾3.3m | — |
| EBITDA margin | 5.4%10.4% | — |
| Net profit | ₾1.9m₾2.8m | ₾1.24bn₾1.12bn |
| Net margin | 5.2%8.8% | 52.8%53.0% |
| Balance sheet | ||
| Total assets | ₾16.6m₾13.4m | ₾37.66bn₾31.77bn |
| Total equity | ₾13.1m₾11.6m | ₾5.45bn₾4.75bn |
| ROE | 14.5%23.9% | 22.8%23.6% |